Benefits of Radioisotope Therapy Over Traditional Cancer Treatments?
According to recent surveys, the global cancer burden is expected to increase by 60% over the next two decades. However, treatment options are also advancing and healthcare researchers are suggesting new therapies for oncogenic disorders to provide new hope for patients. One such innovation in the field of cancer treatment is radioisotope therapy. Compared to conventional methods like chemotherapy and radiation therapy, medical radioisotopes offer a more targeted and effective approach for certain types of cancer. However, what exactly is it, and why is it gaining momentum in the oncology world? Here’s our take on the subject matter!
Primarily, radioisotope therapy involves using radioactive
isotopes, which are atoms that emit radiation, to target cancer cells directly.
By attaching these radioisotopes to molecules that specifically seek out cancer
cells, the treatment can deliver radiation precisely where it’s needed. The medical application of
radioisotopes is a new game-changer because the treatment can minimize damage
to healthy tissues, which is an upgrade over generalized therapies like
chemotherapy.
The lutetium-177 and actinium-225 productions have showcased great
promise in treating different forms of cancer. Let’s delve into the details to
explore why they work and what sets them apart from traditional treatments.
A Brief Overview of Lutetium 177
Lutetium-177 production has
been a game changer for oncogenic treatment. The radioisotope is widely used in
the treatment of prostate cancer and neuroendocrine tumors because it binds to
cancer-specific molecules and emits beta particles, which damage cancer cells
from within. Unlike external radiation, which affects both cancerous and
healthy cells, Lu-177's localized radiation reduces side effects. It is better
than traditional methods because-
- Lu-177 can target cancer cells
directly while preserving surrounding healthy tissues. On the contrary,
traditional radiation therapy affects both cancerous and healthy cells,
which leads to broader side effects.
- With Lu-177, patients also
experience fewer and milder side effects as compared to chemotherapy,
which results in hair loss, nausea, and immunosuppression.
- In addition, many patients also
report better quality of life during and after Lu-177 therapy due to its
precision and less toxicity.
Actinium-225: Precision Treatment
for Hard-to-Treat Cancers
Actinium-225 is another powerful isotope used in radioisotope
therapy, particularly for cancers like leukemia and prostate cancer. This
isotope emits alpha particles, which are larger and more damaging to cancer
cells compared to the beta particles from Lu-177. The isotope can be used
because-
- The alpha particles released by
Ac-225 have a shorter range but pack more energy, ensuring that the
radiation damages only cancer cells, which reduces the risk of harming
nearby healthy tissues.
- Actinium-225 is especially
effective against cancers that have become resistant to other forms of
treatment. For example, some patients with advanced-stage prostate cancer,
who no longer respond to traditional therapy, have seen remarkable results
with Ac-225.
- Actinium-225 is also being
studied in combination with other treatments to enhance its efficacy.
Radioisotopes can be a great breakthrough in cancer treatment,
but their production has been limited by supply outages, technical limitations,
and more. To battle radioisotope
supply chain issues, Nusano offers a wide range of isotopes for professionals
in different industry verticals to aid the fight against cancer.

Comments
Post a Comment